{
    "query_details": {
        "Distance": "10",
        "PageSize": 150,
        "MaxDistance": 500,
        "Age": "50",
        "Gender": "Female",
        "Medical Condition": "Hormone Receptor Positive Breast Cancer",
        "Location": "Tulsa, OK",
        "Latitude": "36.1540",
        "Longitude": "-95.9928"
    },
    "stats": {
        "number_of_trials": 1,
        "trial_names": [
            "Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer"
        ],
        "nct_numbers": "NCT06058377"
    }
}
